Literature DB >> 11409724

NO synthase inhibitors reduce opioid desensitization in rat locus coeruleus neurons in vitro.

M Torrecilla1, J Pineda, L Ugedo.   

Abstract

The aim of this study was to examine by electrophysiological techniques whether nitric oxide (NO) is involved in the development of desensitization to the opioid agonist Met5-enkephalin (ME) in locus coeruleus neurons from rat brain slices. Bath perfusion with ME (0.05-1.6 microM) caused a concentration-dependent reduction in the firing rate of locus coeruleus cells, whereas perfusion with a high concentration of ME (10 microM) desensitized the inhibitory effect of subsequent ME (0.8 microM) applications. However, in slices perfused with the NO synthase inhibitors 7-NI (100 microM), L-NAME (100 microM) or L-NA (100 microM) the ME (10 microM)-induced opioid desensitization was strongly attenuated. The effect of L-NAME was prevented by administration of L-arginine (100 microM). These results suggest that nitric oxide may contribute to opioid desensitization in locus coeruleus neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409724     DOI: 10.1097/00001756-200106130-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  J Biomed Sci       Date:  2006-07-18       Impact factor: 8.410

2.  Exogenous ketone salts inhibit superoxide production in the rat caudal solitary complex during exposure to normobaric and hyperbaric hyperoxia.

Authors:  Christopher M Hinojo; Geoffrey E Ciarlone; Dominic P D'Agostino; Jay B Dean
Journal:  J Appl Physiol (1985)       Date:  2021-03-04

3.  Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo.

Authors:  María Torrecilla; José Angel Ruiz-Ortega; Luisa Ugedo; Joseba Pineda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-05-01       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.